Skip to main content
Top
Published in: BMC Health Services Research 1/2018

Open Access 01-12-2018 | Research article

Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study

Authors: Puttarin Kulchaitanaroaj, Zoltán Kaló, Robert West, Kei Long Cheung, Silvia Evers, Zoltán Vokó, Mickael Hiligsmann, Hein de Vries, Lesley Owen, Marta Trapero-Bertran, Reiner Leidl, Subhash Pokhrel

Published in: BMC Health Services Research | Issue 1/2018

Login to get access

Abstract

Background

The evidence on the extent to which stakeholders in different European countries agree with availability and importance of tobacco-control interventions is limited. This study assessed and compared stakeholders’ views from five European countries and compared the perceived ranking of interventions with evidence-based ranking using cost-effectiveness data.

Methods

An interview survey (face-to-face, by phone or Skype) was conducted between April and July 2014 with five categories of stakeholders - decision makers, service purchasers, service providers, evidence generators and health promotion advocates - from Germany, Hungary, the Netherlands, Spain, and the United Kingdom. A list of potential stakeholders drawn from the research team’s contacts and snowballing served as the sampling frame. An email invitation was sent to all stakeholders in this list and recruitment was based on positive replies. Respondents were asked to rate availability and importance of 30 tobacco control interventions. Kappa coefficients assessed agreement of stakeholders’ views. A mean importance score for each intervention was used to rank the interventions. This ranking was compared with the ranking based on cost-effectiveness data from a published review.

Results

Ninety-three stakeholders (55.7% response rate) completed the survey: 18.3% were from Germany, 17.2% from Hungary, 30.1% from the Netherlands, 19.4% from Spain, and 15.1% from the UK. Of those, 31.2% were decision makers, 26.9% evidence generators, 19.4% service providers, 15.1% health-promotion advocates, and 7.5% purchasers of services/pharmaceutical products. Smoking restrictions in public areas were rated as the most important intervention (mean score = 1.89). The agreement on availability of interventions between the stakeholders was very low (kappa = 0.098; 95% CI = [0.085, 0.111] but the agreement on the importance of the interventions was fair (kappa = 0.239; 95% CI = [0.208, 0.253]). A correlation was found between availability and importance rankings for stage-based interventions. The importance ranking was not statistically concordant with the ranking based on published cost-effectiveness data (Kendall rank correlation coefficient = 0.40; p-value = 0.11; 95% CI = [− 0.09, 0.89]).

Conclusions

The intrinsic differences in stakeholder views must be addressed while transferring economic evidence Europe-wide. Strong engagement with stakeholders, focussing on better communication, has a potential to mitigate this challenge.
Appendix
Available only for authorised users
Literature
3.
go back to reference Levy DT, Chaloupka F, Gitchell J. The effects of tobacco control policies on smoking rates: a tobacco control scorecard. J Public Health Manag Pract: JPHMP. 2004;10:338–53.CrossRefPubMed Levy DT, Chaloupka F, Gitchell J. The effects of tobacco control policies on smoking rates: a tobacco control scorecard. J Public Health Manag Pract: JPHMP. 2004;10:338–53.CrossRefPubMed
5.
go back to reference West R, Raw M, McNeill A, Stead L, Aveyard P, Bitton J, Stapleton J, McRobbie H, Pokhrel S, Lester-George A, et al. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 2015;110:1388–403.CrossRefPubMedPubMedCentral West R, Raw M, McNeill A, Stead L, Aveyard P, Bitton J, Stapleton J, McRobbie H, Pokhrel S, Lester-George A, et al. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 2015;110:1388–403.CrossRefPubMedPubMedCentral
7.
go back to reference Wilson LM, Avila Tang E, Chander G, Hutton HE, Odelola OA, Elf JL, Heckman-Stoddard BM, Bass EB, Little EA, Haberl EB, et al. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. J Environ Public Health. 2012;2012:36.CrossRef Wilson LM, Avila Tang E, Chander G, Hutton HE, Odelola OA, Elf JL, Heckman-Stoddard BM, Bass EB, Little EA, Haberl EB, et al. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. J Environ Public Health. 2012;2012:36.CrossRef
8.
go back to reference Wang S, Moss JR, Hiller JE. Applicability and transferability of interventions in evidence-based public health. Health Promot Int. 2006;21:76–83.CrossRefPubMed Wang S, Moss JR, Hiller JE. Applicability and transferability of interventions in evidence-based public health. Health Promot Int. 2006;21:76–83.CrossRefPubMed
9.
go back to reference Goeree R, Burke N, O'Reilly D, Manca A, Blackhouse G, Tarride JE. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin. 2007;23:671–82.CrossRefPubMed Goeree R, Burke N, O'Reilly D, Manca A, Blackhouse G, Tarride JE. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin. 2007;23:671–82.CrossRefPubMed
10.
go back to reference Boulenger S, Nixon J, Drummond M, Ulmann P, Rice S, de Pouvourville G. Can economic evaluations be made more transferable? The European journal of health economics : HEPAC : health economics in prevention and care. 2005;6:334–46.CrossRefPubMed Boulenger S, Nixon J, Drummond M, Ulmann P, Rice S, de Pouvourville G. Can economic evaluations be made more transferable? The European journal of health economics : HEPAC : health economics in prevention and care. 2005;6:334–46.CrossRefPubMed
11.
go back to reference Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 2009;12:409–18.CrossRefPubMed Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 2009;12:409–18.CrossRefPubMed
12.
go back to reference Vemer P, Rutten-Van Mölken MPMH, Kaper J, Hoogenveen RT, Van Schayck CP, Feenstra TL. If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands. Addiction. 2010;105:1088–97.CrossRefPubMed Vemer P, Rutten-Van Mölken MPMH, Kaper J, Hoogenveen RT, Van Schayck CP, Feenstra TL. If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands. Addiction. 2010;105:1088–97.CrossRefPubMed
13.
go back to reference Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health technology assessment (Winchester, England). 2004;8(iii-iv):1–192. Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health technology assessment (Winchester, England). 2004;8(iii-iv):1–192.
14.
go back to reference Drummond M, Augustovski F, Kaló Z, Yang B-M, Pichon-Riviere A, Bae E-Y, Kamal-Bahl S. Challenges faced in transferring economic evaluations to middle income countries. Int J Technol Assess Health Care. 2016:1–7. Drummond M, Augustovski F, Kaló Z, Yang B-M, Pichon-Riviere A, Bae E-Y, Kamal-Bahl S. Challenges faced in transferring economic evaluations to middle income countries. Int J Technol Assess Health Care. 2016:1–7.
16.
go back to reference Pokhrel S, Evers S, Leidl R, Trapero-Bertran M, Kalo Z, Vries H, Crossfield A, Andrews F, Rutter A, Coyle K, et al. EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. BMJ Open. 2014;4(11):e006945.CrossRefPubMedPubMedCentral Pokhrel S, Evers S, Leidl R, Trapero-Bertran M, Kalo Z, Vries H, Crossfield A, Andrews F, Rutter A, Coyle K, et al. EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. BMJ Open. 2014;4(11):e006945.CrossRefPubMedPubMedCentral
17.
go back to reference Kalo Z, Landa K, Dolezal T, Voko Z. Transferability of National Institute for health and clinical excellence recommendations for pharmaceutical therapies in oncology to central-eastern European countries. Eur J Cancer Care (Engl). 2012;21:442–9.CrossRef Kalo Z, Landa K, Dolezal T, Voko Z. Transferability of National Institute for health and clinical excellence recommendations for pharmaceutical therapies in oncology to central-eastern European countries. Eur J Cancer Care (Engl). 2012;21:442–9.CrossRef
18.
go back to reference Buffett C, Ciliska D, Thomas H: Can I use this evidence in my program decision? Assessing applicability and transferability of evidence. 2007. Buffett C, Ciliska D, Thomas H: Can I use this evidence in my program decision? Assessing applicability and transferability of evidence. 2007.
20.
go back to reference Burchett HED, Mayhew SH, Lavis JN, Dobrow MJ. When can research from one setting be useful in another? Understanding perceptions of the applicability and transferability of research. Health Promot Int. 2013;28:418–30.CrossRefPubMed Burchett HED, Mayhew SH, Lavis JN, Dobrow MJ. When can research from one setting be useful in another? Understanding perceptions of the applicability and transferability of research. Health Promot Int. 2013;28:418–30.CrossRefPubMed
21.
go back to reference Cheung KL, Evers SMAA, Hiligsmann M, Vokó Z, Pokhrel S, Jones T, Muñoz C, Wolfenstetter SB, Józwiak-Hagymásy J, de Vries H. Understanding the stakeholders’ intention to use economic decision-support tools: a cross-sectional study with the tobacco return on investment tool. Health Policy. 2016;120:46–54.CrossRefPubMed Cheung KL, Evers SMAA, Hiligsmann M, Vokó Z, Pokhrel S, Jones T, Muñoz C, Wolfenstetter SB, Józwiak-Hagymásy J, de Vries H. Understanding the stakeholders’ intention to use economic decision-support tools: a cross-sectional study with the tobacco return on investment tool. Health Policy. 2016;120:46–54.CrossRefPubMed
22.
go back to reference Owen L, Morgan A, Fischer A, Ellis S, Hoy A, Kelly MP. The cost-effectiveness of public health interventions. J Public Health (Oxf). 2012;34:37–45.CrossRef Owen L, Morgan A, Fischer A, Ellis S, Hoy A, Kelly MP. The cost-effectiveness of public health interventions. J Public Health (Oxf). 2012;34:37–45.CrossRef
23.
go back to reference Voko Z, Cheung KL, Jozwiak-Hagymasy J, Wolfenstetter S, Jones T, Munoz C, Evers SM, Hiligsmann M, de Vries H, Pokhrel S. Similarities and differences between stakeholders' opinions on using health technology assessment (HTA) information across five European countries: results from the EQUIPT survey. Health Res Policy Syst. 2016;14:38.CrossRefPubMedPubMedCentral Voko Z, Cheung KL, Jozwiak-Hagymasy J, Wolfenstetter S, Jones T, Munoz C, Evers SM, Hiligsmann M, de Vries H, Pokhrel S. Similarities and differences between stakeholders' opinions on using health technology assessment (HTA) information across five European countries: results from the EQUIPT survey. Health Res Policy Syst. 2016;14:38.CrossRefPubMedPubMedCentral
24.
go back to reference Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.PubMed Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.PubMed
29.
go back to reference Burchett HE, Dobrow MJ, Lavis JN, Mayhew SH. The applicability and transferability of public health research from one setting to another: a survey of maternal health researchers. Glob Health Promot. 2013;20:16–24.CrossRefPubMed Burchett HE, Dobrow MJ, Lavis JN, Mayhew SH. The applicability and transferability of public health research from one setting to another: a survey of maternal health researchers. Glob Health Promot. 2013;20:16–24.CrossRefPubMed
Metadata
Title
Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study
Authors
Puttarin Kulchaitanaroaj
Zoltán Kaló
Robert West
Kei Long Cheung
Silvia Evers
Zoltán Vokó
Mickael Hiligsmann
Hein de Vries
Lesley Owen
Marta Trapero-Bertran
Reiner Leidl
Subhash Pokhrel
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2018
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-2923-2

Other articles of this Issue 1/2018

BMC Health Services Research 1/2018 Go to the issue